Use of palivizumab with other infection control measures to control respiratory syncytial virus outbreaks in neonatal care units
Conclusion: During nosocomial outbreaks of RSV, administration of palivizumab to all infants in NICU appears to be rational and may help contain outbreaks.
Source: Journal of Tropical Pediatrics - Category: Tropical Medicine Authors: Hammoud, M. S., Al-Taiar, A., Raina, A., Elsori, D., Al-Qabandi, S., Al-Essa, M. Tags: Original Papers Source Type: research
More News: Intensive Care | Outbreaks | Pediatrics | Perinatology & Neonatology | Respiratory Medicine | Tropical Medicine